Keeping things flowing from end to end with Biodot

DCN Dx offers end-to-end services – from assay development and validation to manufacturing and clinical research services – and relies on BioDot equipment for its deposition needs. Dr Pat Vaughan, Chief Operating Officer at DCN Dx, explains how the company has elevated its lateral flow test manufacturing with support from Biodot, and how DCN Dx has continued to grow as a contract research development and manufacturing (CRDMO) service for in vitro diagnostics.